These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25078042)

  • 21. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
    Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation?
    Keohane J; O'Mahony C; O'Mahony L; O'Mahony S; Quigley EM; Shanahan F
    Am J Gastroenterol; 2010 Aug; 105(8):1788, 1789-94; quiz 1795. PubMed ID: 20389294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study.
    David LE; Surdea-Blaga T; Dumitrascu DL
    Sao Paulo Med J; 2015; 133(4):343-9. PubMed ID: 26039537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?].
    Mearin F; Perelló A; Balboa A
    Gastroenterol Hepatol; 2009 May; 32(5):364-72. PubMed ID: 19442413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity.
    Berrill JW; Green JT; Hood K; Campbell AK
    Aliment Pharmacol Ther; 2013 Jul; 38(1):44-51. PubMed ID: 23668698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease.
    Shutkever O; Gracie DJ; Young C; Wood HM; Taylor M; John Hamlin P; Ford AC; Quirke P
    Inflamm Bowel Dis; 2018 Jun; 24(7):1597-1605. PubMed ID: 29668957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease.
    Pedersen N; Ankersen DV; Felding M; Wachmann H; Végh Z; Molzen L; Burisch J; Andersen JR; Munkholm P
    World J Gastroenterol; 2017 May; 23(18):3356-3366. PubMed ID: 28566897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease.
    Jones MP; Wessinger S; Crowell MD
    Clin Gastroenterol Hepatol; 2006 Apr; 4(4):474-81. PubMed ID: 16616353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
    Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.
    Maagaard L; Ankersen DV; Végh Z; Burisch J; Jensen L; Pedersen N; Munkholm P
    World J Gastroenterol; 2016 Apr; 22(15):4009-19. PubMed ID: 27099444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.
    Menees SB; Powell C; Kurlander J; Goel A; Chey WD
    Am J Gastroenterol; 2015 Mar; 110(3):444-54. PubMed ID: 25732419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial.
    Hoekman DR; Vlieger AM; Stokkers PC; Mahhmod N; Rietdijk S; de Boer NK; de Meij TG; Frankenhuis C; D'Haens GR; Benninga MA
    J Crohns Colitis; 2021 Jul; 15(7):1106-1113. PubMed ID: 33245332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome.
    Begtrup LM; Engsbro AL; Kjeldsen J; Larsen PV; Schaffalitzky de Muckadell O; Bytzer P; Jarbøl DE
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):956-62.e1. PubMed ID: 23357491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet.
    Jones MP; Bratten J; Keefer L
    Am J Gastroenterol; 2007 Oct; 102(10):2232-7. PubMed ID: 17680842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of calprotectin in irritable bowel syndrome and in inflammatory bowel disease.
    Grad C; David L; Portincasa P; Dumitraşcu DL
    Rom J Intern Med; 2012; 50(1):3-6. PubMed ID: 22788087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irritable Bowel-like Symptoms in Ulcerative Colitis are as Common in Patients in Deep Remission as in Inflammation: Results From a Population-based Study [the IBSEN Study].
    Henriksen M; Høivik ML; Jelsness-Jørgensen LP; Moum B;
    J Crohns Colitis; 2018 Mar; 12(4):389-393. PubMed ID: 29186372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calprotectin Is a Useful Tool in Distinguishing Coexisting Irritable Bowel-Like Symptoms from That of Occult Inflammation among Inflammatory Bowel Disease Patients in Remission.
    Jelsness-Jørgensen LP; Bernklev T; Moum B
    Gastroenterol Res Pract; 2013; 2013():620707. PubMed ID: 23476638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anhedonia in irritable bowel syndrome and in inflammatory bowel diseases and its relationship with abdominal pain.
    Carpinelli L; Bucci C; Santonicola A; Zingone F; Ciacci C; Iovino P
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13531. PubMed ID: 30628137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comparative Study of Quality of Life in Persons With Irritable Bowel Syndrome and Inflammatory Bowel Disease.
    Blagden S; Kingstone T; Soundy A; Lee R; Singh S; Roberts L
    Gastroenterol Nurs; 2015; 38(4):268-78. PubMed ID: 26226021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS.
    Di Nardo G; Barbara G; Cucchiara S; Cremon C; Shulman RJ; Isoldi S; Zecchi L; Drago L; Oliva S; Saulle R; Barbaro MR; Stronati L
    Neurogastroenterol Motil; 2014 Feb; 26(2):196-204. PubMed ID: 24304324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.